Management

Walter Korz, Vice President, General Manager

Mr. Korz joined the Company in November 2010. His multi-disciplinary experience has spanned 20 years in the biotech sector with a number of emerging and established companies as well as 10 years in the public health care sector. Mr. Korz brings with him a broad drug development background with experience in business development, finance, clinical development, regulatory affairs, and project outsourcing. He previously served as Vice President, Drug Development and later stepping in as President and CEO of Chemokine Therapeutics Corp. Mr. Korz held the position of Clinical Development Manager with Angiotech Pharmaceuticals, Inc. overseeing the systemic therapy programs including one of the largest multiple sclerosis clinical trials conducted in Canada. With AltaRex Corp. he was responsible for the development of therapeutic products while serving in Edmonton and Boston. His initial drug development, clinical, and regulatory experiences were gained with Biomira Research Inc. Mr. Korz was educated at the University of Alberta, Southern Alberta Institute of Technology and the University of Saskatchewan. He obtained his Masters of Business Administration from Athabasca University.

James C.N Oon, Asia Director

Mr. Oon, MBA, MSc, is a seasoned pharmaceutical professional. He has more than 20 years of diverse global experience and cumulative expertise in manufacturing technology, control management, regulatory and GxP compliance enforcement. This includes 3 years as a GMP (Good Manufacturing Practice) Consultant serving the Life Science Industry in China, Malaysia and Singapore. He started his career with Beecham Pharmaceutical (now GlaxoSmithKline), and since then has held positions of increasing responsibility in Fisons Pte Ltd (now Sanofi Aventis), Schering-Plough Ltd (now Merck Sharp & Dohme), Ck Life Sciences and WEX Pharmaceuticals Inc. During his long career he participated in many major projects namely Amoxycillin Project (Smithkline Beecham), Nedocromil Sodium Bulk Pharmaceutical Project (Fisons) and Organic Synthesis & Steroids Project (Schering-Plough), all of which were developed from green field sites. He participated in the design, Hazop review, GMP review, Contract Management and Validation and Commissioning of these facilities. Under his leadership, he achieved successful inspections by the US FDA (Food & Drug Administration of United States of America) which granted approval to these facilities for export of pharmaceutical products to the United States. Mr. Oon was educated in Sheffield University, England where he obtained Bachelor of Technical Science Honours degree and Master of Science in Chemical Engineering, and Masters of Business of Administration from Leicester University, England. He is the Asia Director of WEX Pharmaceuticals Inc., having overall responsibilities in Chemistry, Manufacturing and Control (CMC).